Could 3D models of cancer enhance drug screening?

Virginia Brancato; Joaquím M. Oliveira; Vítor M. Correlo; Rui L Reis; Subhas C. Kundu

doi:10.1016/j.biomaterials.2019.119744

Related publications

Article2021

High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids

Nicholas Choo, Susanne Ramm, Jennii Luu, Jean M. Winter, Luke A. Selth, Amy R. Dwyer, Mark Frydenberg, Jeremy Grummet, Shahneen Sandhu, Theresa E. Hickey, Wayne D. Tilley, Renea A. Taylor, Gail P. Risbridger, Mitchell G. Lawrence, Kaylene J. Simpson

Editorial Material2022

Forecast cancer: the importance of biomimetic 3D in vitro models in cancer drug testing/discovery and therapy

David Caballero, Banani Kundu, Catarina M. Abreu, Sara Amorim, Diogo Fernandes, Ricardo A. Pires, Joaquím M. Oliveira, Vítor M. Correlo, Rui L Reis, Subhas C. Kundu

Article2020

Establishment of patient-derived cancer organoids for drug-screening applications

Else Driehuis, Kai Kretzschmar, Hans Clevers

Article2021

Breast tumor-on-chip models: From disease modeling to personalized drug screening

Subia Bano, Ujjwal R. Dahiya, Sarita Mishra, Jessica Ayache, Guilhem Velvé Casquillas, David Caballero, Rui L Reis, Subhas C. Kundu

Chapter in a book2010

Screening Models

Michael M. Morgan, MacDonald J. Christie, Luı́s de Lecea, Jason C. G. Halford, Josée E. Leysen, Warren H. Meck, Catalin V. Buhusi, Marcy J. Bubar, Kathryn A. Cunningham, Marcy J. Bubar, Kathryn A. Cunningham, Richard W. Foltin, David C. S. Roberts, Andreas Marneros, Andreas Marneros, Alex Hofer, Bart Ellenbroek, Christoph U. Correll, Paul Newhouse, Heather Wilkins, Bart Ellenbroek, Joris C. Verster, Emma Childs, Gary Remington, Edoardo Spina, W. Wolfgang Fleischhacker, ,